These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26524624)

  • 21. Exendin-4 regulates glucokinase expression by CaMKK/CaMKIV pathway in pancreatic beta-cell line.
    Murao K; Li J; Imachi H; Muraoka T; Masugata H; Zhang GX; Kobayashi R; Ishida T; Tokumitsu H
    Diabetes Obes Metab; 2009 Oct; 11(10):939-46. PubMed ID: 19486109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
    Smith GC; Vickers MH; Cognard E; Shepherd PR
    Schizophr Res; 2009 Nov; 115(1):30-40. PubMed ID: 19679451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system.
    Castro MC; Francini F; Schinella G; Caldiz CI; Zubiría MG; Gagliardino JJ; Massa ML
    Clin Sci (Lond); 2012 Dec; 123(12):681-92. PubMed ID: 22738259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium's effects on rat liver glucose metabolism in vivo.
    Rodriguez-Gil JE; Fernández-Novell JM; Barberá A; Guinovart JJ
    Arch Biochem Biophys; 2000 Mar; 375(2):377-84. PubMed ID: 10700396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.
    Pathak R; Kumar A; Palfrey HA; Forney LA; Stone KP; Raju NR; Gettys TW; Murthy SN
    Inflamm Res; 2019 Jul; 68(7):581-595. PubMed ID: 31073849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.
    Cullen KS; Al-Oanzi ZH; O'Harte FP; Agius L; Arden C
    Biochim Biophys Acta; 2014 Jun; 1843(6):1123-34. PubMed ID: 24566088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.
    Wang Y; Perfetti R; Greig NH; Holloway HW; DeOre KA; Montrose-Rafizadeh C; Elahi D; Egan JM
    J Clin Invest; 1997 Jun; 99(12):2883-9. PubMed ID: 9185511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor counteracts insulin-induced expression of glucokinase in hepatocytes.
    Beresford GW; Agius L
    Biochem Biophys Res Commun; 1994 Jun; 201(2):902-8. PubMed ID: 8003030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes.
    Payne VA; Arden C; Wu C; Lange AJ; Agius L
    Diabetes; 2005 Jul; 54(7):1949-57. PubMed ID: 15983194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.
    Ma X; Meng J; Jia M; Bi L; Zhou Y; Wang Y; Hu J; He G; Luo X
    J Bone Miner Res; 2013 Jul; 28(7):1641-52. PubMed ID: 23427056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia.
    Nuche-Berenguer B; Lozano D; Gutiérrez-Rojas I; Moreno P; Mariñoso ML; Esbrit P; Villanueva-Peñacarrillo ML
    J Endocrinol; 2011 May; 209(2):203-10. PubMed ID: 21372151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulatory protein of liver glucokinase.
    van Schaftingen E; Vandercammen A; Detheux M; Davies DR
    Adv Enzyme Regul; 1992; 32():133-48. PubMed ID: 1496915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the stimulatory effect of a potassium-rich medium on the phosphorylation of glucose in isolated rat hepatocytes.
    Van Schaftingen E; Vandercammen A
    Eur J Biochem; 1992 Feb; 204(1):363-9. PubMed ID: 1740148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic behaviour of liver glucokinase in insulinopenic situations: effect of fructose 1-phosphate in fed and starved rats.
    Zähner D; Malaisse WJ
    Biochimie; 1990 Oct; 72(10):715-8. PubMed ID: 2078589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate.
    Van Schaftingen E
    Eur J Biochem; 1989 Jan; 179(1):179-84. PubMed ID: 2917560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation.
    Watford M
    Nutr Rev; 2002 Aug; 60(8):253-7. PubMed ID: 12199300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism by which rat liver glucokinase is inhibited by the regulatory protein.
    Vandercammen A; Van Schaftingen E
    Eur J Biochem; 1990 Jul; 191(2):483-9. PubMed ID: 2384095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.